National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical utilization of cardiac biomarker testing in heart failure

被引:210
作者
Tang, W. H. Wilson
Francis, Gary S.
Morrow, David A.
Newby, L. Kristin
Cannon, Christopher P.
Jesse, Robert L.
Storrow, Alan B.
Christenson, Robert H.
Christenson, Robert H.
Apple, Fred S.
Cannon, Christopher P.
Francis, Gary S.
Jesse, Robert L.
Morrow, David A.
Newby, L. Kristin
Ravkilde, Jan
Storrow, Alan B.
Tang, W. H. Wilson
Wu, Alan H. B.
机构
关键词
D O I
10.1161/CIRCULATIONAHA.107.185267
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:E99 / E109
页数:11
相关论文
共 148 条
[91]   Non-competitive immunochemiluminometric assay for cardiotrophin-I detects elevated plasma levels in human heart failure [J].
Ng, LL ;
O'Brien, RJ ;
Demme, B ;
Jennings, S .
CLINICAL SCIENCE, 2002, 102 (04) :411-416
[92]   Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population [J].
Nielsen, OW ;
McDonagh, TA ;
Robb, SD ;
Dargie, HJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :113-120
[93]   Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF [J].
O'Brien, RJ ;
Squire, IB ;
Demme, B ;
Davies, JE ;
Ng, LL .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (04) :499-506
[94]   Myotrophin in human heart failure [J].
O'Brien, RJ ;
Loke, I ;
Davies, JE ;
Squire, IB ;
Ng, LL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :719-725
[95]   The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients [J].
O'Hanlon, Rory ;
O'Shea, Paula ;
Ledwidge, Mark ;
O'Loughlin, Christina ;
Lange, Sophie ;
Conlon, Carmel ;
Phelan, Dermot ;
Cunningham, Sean ;
Mcdonald, Ken .
JOURNAL OF CARDIAC FAILURE, 2007, 13 (01) :50-55
[96]   B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure [J].
O'Neill, JO ;
Bott-Silverman, CE ;
McRae, AT ;
Troughton, RW ;
Ng, K ;
Starling, RC ;
Young, JB .
AMERICAN HEART JOURNAL, 2005, 149 (02) :363-369
[97]   N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes [J].
Omland, T ;
Persson, A ;
Ng, L ;
O'Brien, R ;
Karlsson, T ;
Herlitz, J ;
Hartford, M ;
Caidahl, K .
CIRCULATION, 2002, 106 (23) :2913-2918
[98]   Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? [J].
Packer, M .
CIRCULATION, 2003, 108 (24) :2950-2953
[99]   Ongoing myocardial injury in stable severe heart failure -: Value of cardiac troponin T monitoring for high-risk patient identification [J].
Perna, ER ;
Macin, SM ;
Canella, JPC ;
Augier, N ;
Stival, JLR ;
Cialzeta, JR ;
Pitzus, AE ;
Garcia, EH ;
Obregón, R ;
Brizuela, M ;
Barbagelata, A .
CIRCULATION, 2004, 110 (16) :2376-2382
[100]   Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure [J].
Perna, ER ;
Macín, SM ;
Canella, JPC ;
Alvarenga, PM ;
Ríos, NG ;
Pantich, R ;
Augier, N ;
Farías, EF ;
Jantus, E ;
Brizuela, M ;
Medina, F .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (02) :253-261